Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Inspire Medical Systems Inc (NY: INSP )

131.54 +5.75 (+4.58%)
Streaming Delayed Price Updated: 12:15 PM EDT, Jul 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inspire Medical Systems Inc

< Previous 1 2 3 4 5 6 7 Next >
INSPIRE MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Deep Dive Into Inspire Medical Systems Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
FDA Labels Inspire Medical's Sleep Apnea Nerve Stimulator Recall As Most Serious
Inspire Medical Systems recalls Model 3028 IPG due to manufacturing defect causing serious health risks. Learn about the FDA Class I recall implications and patient advisories. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. 
Via MarketBeat
Exposures Product Safety
What Analysts Are Saying About Inspire Medical Systems Stock
Via Benzinga
Expert Ratings For Inspire Medical Systems
Via Benzinga
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
Via Benzinga
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
Eli Lilly tested its weight-loss drug in people with obesity suffering from sleep apnea events. 
Via Investor's Business Daily
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock,
Jim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported better-than-expected first-quarter financial results. 
Via Benzinga
7 Undervalued Stocks That Could Triple Your Money by 2026
These seven undervalued stocks have the potential to triple investors' money by 2026 once the market fully recognizes their value. 
Via InvestorPlace
The Latest Analyst Ratings For Inspire Medical Systems
Via Benzinga
Dow Gains 150 Points; Emerson Electric Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Moves Higher; Inspire Medical Systems Shares Plummet
Via Benzinga
Exposures Fossil Fuels
Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're diving into the biggest pre-market stock movers for Wednesday will a look at all of the latest news happening this morning. 
Via InvestorPlace
Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
INSP Stock Earnings: Inspire Medical Systems Beats EPS, Beats Revenue for Q1 2024
INSP stock results show that Inspire Medical Systems beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78. 
Via Investor's Business Daily
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
INSPIRE MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INSP DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May... 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
INSP DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inspire Medical Systems, Inc. Investors with Losses to Secure Counsel Before Important February 20 Deadline in Securities Class Action - INSP
WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May... 
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
INSPIRE MEDICAL 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Inspire Medical Systems, Inc. - INSP
From Kahn Swick & Foti, LLC
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inspire Medical Systems, Inc. (INSP)
From The Law Offices of Frank R. Cruz
Via Business Wire
INSPIRE MEDICAL INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inspire Medical To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.